Shenzhen Weiguang Biological Products Co Ltd (002880) - Cash Flow Conversion Efficiency

Latest as of September 2025: 0.022x

Based on the latest financial reports, Shenzhen Weiguang Biological Products Co Ltd (002880) has a cash flow conversion efficiency ratio of 0.022x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CN¥51.60 Million ≈ $7.55 Million USD) by net assets (CN¥2.36 Billion ≈ $344.86 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See 002880 days of operational coverage to measure how many days the company can operate on defensive assets alone.

Shenzhen Weiguang Biological Products Co Ltd - Cash Flow Conversion Efficiency Trend (2012–2025)

This chart illustrates how Shenzhen Weiguang Biological Products Co Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data.

Shenzhen Weiguang Biological Products Co Ltd Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Shenzhen Weiguang Biological Products Co Ltd ranked by their cash flow conversion efficiency.

Company	Cash Flow Conversion Efficiency
Burelle SA PA:BUR	0.141x
Alerus Financial Corp NASDAQ:ALRS	0.048x
Friend Co Ltd SHG:605050	N/A
Shanghai Zhongyida Co Ltd A SHG:600610	0.483x
Isgec Heavy Engineering Limited NSE:ISGEC	0.154x
Lahav LR Real Estate Ltd TA:LAHAV	0.011x
Era Co Ltd SHE:002641	0.002x
Guangdong Biolight Meditech Co Ltd SHE:300246	0.052x

Annual Cash Flow Conversion Efficiency for Shenzhen Weiguang Biological Products Co Ltd (2012–2025)

The table below shows the annual cash flow conversion efficiency of Shenzhen Weiguang Biological Products Co Ltd from 2012 to 2025. For the full company profile with market capitalisation and key ratios, see Shenzhen Weiguang Biological Products Co market cap and net worth.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2025-12-31	CN¥2.45 Billion ≈ $357.80 Million	CN¥263.18 Million ≈ $38.51 Million	0.108x	+35.89%
2024-12-31	CN¥2.24 Billion ≈ $328.40 Million	CN¥177.77 Million ≈ $26.01 Million	0.079x	-59.28%
2023-12-31	CN¥2.05 Billion ≈ $299.34 Million	CN¥397.94 Million ≈ $58.23 Million	0.195x	+30198.49%
2022-12-31	CN¥1.87 Billion ≈ $273.28 Million	CN¥1.20 Million ≈ $175.46K	0.001x	-99.53%
2021-12-31	CN¥1.79 Billion ≈ $261.68 Million	CN¥246.89 Million ≈ $36.13 Million	0.138x	-26.25%
2020-12-31	CN¥1.62 Billion ≈ $237.61 Million	CN¥303.96 Million ≈ $44.48 Million	0.187x	+46.04%
2019-12-31	CN¥1.45 Billion ≈ $212.00 Million	CN¥185.70 Million ≈ $27.17 Million	0.128x	+68.15%
2018-12-31	CN¥1.31 Billion ≈ $191.08 Million	CN¥99.54 Million ≈ $14.57 Million	0.076x	+220.52%
2017-12-31	CN¥1.20 Billion ≈ $176.06 Million	CN¥28.61 Million ≈ $4.19 Million	0.024x	-90.47%
2016-12-31	CN¥506.44 Million ≈ $74.11 Million	CN¥126.41 Million ≈ $18.50 Million	0.250x	-34.53%
2015-12-31	CN¥393.71 Million ≈ $57.61 Million	CN¥150.09 Million ≈ $21.96 Million	0.381x	-12.24%
2014-12-31	CN¥308.86 Million ≈ $45.20 Million	CN¥134.17 Million ≈ $19.63 Million	0.434x	+364.69%
2013-12-31	CN¥223.88 Million ≈ $32.76 Million	CN¥20.93 Million ≈ $3.06 Million	0.093x	-89.11%
2012-12-31	CN¥135.00 Million ≈ $19.76 Million	CN¥115.88 Million ≈ $16.96 Million	0.858x	--

About Shenzhen Weiguang Biological Products Co Ltd

SHE:002880 China Biotechnology

Market Cap

$736.11 Million

CN¥5.03 Billion CNY

Market Cap Rank

#10452 Global

#2871 in China

Share Price

CN¥22.18

Change (1 day)

+0.18%

52-Week Range

CN¥21.93 - CN¥31.04

All Time High

CN¥963796.17